Home Tags

View the Latest: Food and Drug Administration (FDA)

Filter

List Grid

1 - 10 of 21 Results

  • Supreme Court Leaves Mifepristone Access Unchanged – For Now

    Quick Insights

    In addition to ongoing litigation, last September the Trump administration FDA, after  requests from anti-abortion organizations and state attorneys general, initiated an internal review of mifepristone’s safety.  This adds uncertainty as the agency could revise dispensing rules independently of the courts. With the FDA commissioner’s resignation this week and no permanent leader in place, the timeline for completing the review remains unclear. 

  • KFF Poll Finds That Most Adults Lack Confidence in Key Health Agencies to Act Independently — The Monitor

    Feature

    KFF’s latest Health Tracking Poll finds that confidence in the independence of key government health agencies overseeing food and drug safety and public health is low among the public and across partisans. Most of the public also share a distrust of agriculture, food, and pharmaceutical companies to act in the public’s best interest, compared with doctors and health care providers who are much more trusted among the public. The latest edition of the Monitor also…

  • Louisiana v. FDA: Access to Mifepristone Back at the Supreme Court

    Issue Brief

    This brief reviews the case now before the Supreme Court, Louisiana v. FDA, and provides an overview of the other pending litigation involving mifepristone, and the mounting tension between states seeking to protect abortion and the states banning the provision of abortion.

  • KFF Health Tracking Poll: MAHA and the Midterms

    Poll Finding

    This KFF Health Tracking Poll finds that the cost of health care is a more prominent focus for Make America Healthy Again (MAHA) voters than issues like food and vaccine policy. Four in ten MAHA voters (42%) choose lowering health costs as the most important health priority, outranking other MAHA priorities.

  • Poll: Trust and Confidence in the CDC Remain at Low Point After Changes to Recommended Childhood Vaccines; More Say the Changes Will Hurt than Help Children’s Health

    News Release

    In the weeks after the Trump administration reduced the number of recommended childhood vaccines for routine use, the public’s trust in the CDC remains at its lowest point. Among those who have heard about the recent changes to the recommended childhood vaccine schedule, more say they expect the changes to have a negative impact than a positive one on children’s health.

  • KFF Tracking Poll on Health Information and Trust: Trust in the CDC and Views of Federal Childhood Vaccine Schedule Changes

    Poll Finding

    Weeks after the Trump administration reduced the number of childhood vaccine recommended for routine use, public trust in the CDC is at its lowest since the COVID-19 pandemic, and less than half are confident in federal agencies' ability to make such recommendations. Among those who have heard about the revised recommendations, more say they expect the changes to have a negative impact than a positive one on children’s health.

  • KFF Health Tracking Poll: Knowledge and Views of Medication Abortion

    Poll Finding

    This KFF Health Tracking Poll finds that many, including women of reproductive age, remain unfamiliar with key facts about mifepristone. Fewer than half of all adults say they believe abortion pills are safe now, compared to over half of all adults two years ago. This poll explores awareness and perception of the recent FDA review of the medication, and support for policies aimed at restricting it.